The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy: a scoping review
Crossref DOI link: https://doi.org/10.1007/s10741-024-10476-w
Published Online: 2024-12-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Othman, Leen
Koskina, Lida
Huerta, Nicholas
Rao, Shiavax J.
Text and Data Mining valid from 2024-12-17
Version of Record valid from 2024-12-17
Article History
Accepted: 9 December 2024
First Online: 17 December 2024
Declarations
:
: The authors declare no competing interests.